Adamis Pharmaceuticals Corp (NASDAQ:ADMP) shares are shooting up 34% faster than Jack’s magic bean sparking right into a giant beanstalk. The reason?
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) announced the submission of an Investigational New Drug (IND) application to the U.S.
Adamis Stock Can Reach $13 as Symjepi Deal Is Imminent
Celsion Withdraws Stock Offering Celsion Corporation (NASDAQ:CLSN) shares are on a massive upswing, climbing nearly 110% in pre-market trading Friday on the heels of the …
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) is plummeting nearly 50% down to $4.55 after the FDA rejected the company’s New Drug Application for the second …
